Concord Drugs Limited (BOM:538965)

Concord Drugs Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 28, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	621	311	352	256	254	254
Market Cap Growth	6.02%	-11.63%	37.54%	0.84%	-0.17%	146.63%
Enterprise Value	811	501	521	428	362	351
Last Close Price	62.05	31.08	35.17	27.45	29.00	29.05
PE Ratio	146.40	92.45	74.45	25.95	15.91	7.74
PS Ratio	1.32	0.69	0.78	0.49	0.43	0.49
PB Ratio	1.82	0.91	1.04	0.81	0.89	0.95
P/TBV Ratio	1.82	0.91	1.04	0.81	0.89	0.95
P/FCF Ratio	-	22.37	-	31.71	-	-
P/OCF Ratio	-	8.35	44.39	15.38	32.75	1567937.89
EV/Sales Ratio	1.72	1.11	1.16	0.82	0.61	0.68
EV/EBITDA Ratio	19.04	12.12	12.88	9.36	6.37	10.63
EV/EBIT Ratio	28.36	18.54	20.93	14.52	9.24	18.11
EV/FCF Ratio	-	36.08	-	53.05	-	-
Debt / Equity Ratio	0.56	0.56	0.52	0.54	0.58	0.49
Debt / EBITDA Ratio	4.52	4.65	4.33	3.71	2.89	3.92
Debt / FCF Ratio	-	13.85	-	21.04	-	-
Asset Turnover	-	0.73	0.77	0.91	1.11	0.95
Inventory Turnover	-	1.46	1.57	2.22	2.90	3.07
Quick Ratio	-	0.53	0.94	0.74	0.97	1.28
Current Ratio	-	1.56	2.09	2.01	1.77	2.22
Return on Equity (ROE)	-	0.99%	1.44%	3.28%	5.78%	13.06%
Return on Assets (ROA)	-	2.73%	2.66%	3.21%	4.60%	2.25%
Return on Capital (ROIC)	3.41%	3.23%	3.11%	3.94%	5.79%	3.33%
Return on Capital Employed (ROCE)	-	6.90%	6.60%	8.00%	11.90%	5.80%
Earnings Yield	0.69%	1.08%	1.34%	3.85%	6.29%	12.92%
FCF Yield	-	4.47%	-0.64%	3.15%	-6.63%	-14.46%
Buyback Yield / Dilution	-0.53%	1.12%	-7.35%	-6.53%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.